{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Tumour Growth Model in Absense of Treatment with a Constant Gaussian Error"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The tumour growth inhibitory effects of Erlotinib and Gefitinib were modelled with a population PKPD model in [1]. A population PKPD model is a hierarchical model which consists of a structural model, a population model, and an error model. Each sub-model captures a different aspect of the tumour growth inhibition biology, and is parametrised by a set of parameters.\n",
    "\n",
    "We introduced the structural model proposed in [1] in [n1] and guranteed that the model parameters are identifiable by transforming the search space [n2].\n",
    "\n",
    "In this notebook we model the error of the structural lung cancer growth model in absence of treatment. In particular we will choose a Gaussian error of the model output that does not depend on the tumour volume."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Bibliography\n",
    "\n",
    "- <a name=\"ref1\"> [1] </a> Eigenmann et. al., Combining Nonclinical Experiments with Translational PKPD Modeling to Differentiate Erlotinib and Gefitinib, Mol Cancer Ther (2016)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Notebook references\n",
    "\n",
    "- <a name=\"ref1\"> [n1] </a> [Structural Lung Cancer Growth Model in Absence of Treatment](https://nbviewer.jupyter.org/github/DavAug/ErlotinibGefitinib/blob/master/notebooks/lung_cancer/control_growth/structural_model.ipynb)\n",
    "- <a name=\"ref1\"> [n2] </a> [Identifiability of Structural Model for Lung Cancer Growth in Absence of Treatment](https://nbviewer.jupyter.org/github/DavAug/ErlotinibGefitinib/blob/master/notebooks/lung_cancer/control_growth/identifiability_structural_model.ipynb)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "[Back to project overview](https://github.com/DavAug/ErlotinibGefitinib/blob/master/README.md) | [Back to lung cancer control growth overview](https://nbviewer.jupyter.org/github/DavAug/ErlotinibGefitinib/blob/master/notebooks/lung_cancer/control_growth/overview.ipynb) | [Back to lung cancer control growth error model overview](https://nbviewer.jupyter.org/github/DavAug/ErlotinibGefitinib/blob/master/notebooks/lung_cancer/control_growth/error_model.ipynb)"
   ]
  }
 ],
 "metadata": {
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": 3
  },
  "orig_nbformat": 2
 },
 "nbformat": 4,
 "nbformat_minor": 2
}